NICE says yes to Braftovi combination for colorectal cancerTwo months after rejecting Pierre Fabre’s Braftovi for a rare form of metastatic colorectal cancer (mCRC), NICE has Share XNICE says yes to Braftovi combination for colorectal cancerhttps://pharmaphorum.com/news/nice-says-yes-to-braftovi-combination-for-colorectal-cancer/
